Literature DB >> 12121919

Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae.

Nir Osherov1, Gregory S May, Nathaniel D Albert, D P Kontoyiannis.   

Abstract

Caspofungin inhibits the synthesis of 1, 3-beta-D-glucan, an essential cell wall target in fungi. Genetic studies in the model yeast Saccharomyces cerevisiae have shown that mutations in FKS1 and FKS2 genes result in caspofungin resistance. However, direct demonstration of the role of gene overexpression in caspofungin resistance has been lacking. We transformed wild-type S. cerevisiae with an S. cerevisiae URA3-based GAL1 cDNA library and selected transformants in glucose synthetic complete plates lacking uracil (glucose SC minus uracil plates). We then moved the transformants to galactose SC minus uracil plates containing caspofungin (1 microg/ml) and looked for caspofungin-resistant colonies. We retested the candidates (true positives were sensitive on glucose caspofungin and resistant on galactose caspofungin media, respectively). We identified 16 caspofungin-resistant candidates. Restriction analysis and hybridization confirmed that 15 of the 16 clones were identical. We sequenced one of the cDNA clones and found that it contained the cDNA for SBE2. SBE2 has been described in S. cerevisiae to encode a Golgi protein involved in the transport of cell wall components (B. Santos and M. Snyder, Mol. Biol. Cell, 11:435-452, 2000). The SBE2 cDNA plasmid conferred again galactose-dependent caspofungin resistance when transformed back into the wild-type S. cerevisiae. Finally, the SBE2 deletion mutant was hypersensitive to caspofungin. In conclusion, overexpression of Sbe2p under the regulated control of the GAL1 promoter results in caspofungin resistance in S. cerevisiae. This transport pathway may provide insight into the tolerance or lack of sensitivity to caspofungin of some pathogenic fungi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121919      PMCID: PMC127366          DOI: 10.1128/AAC.46.8.2462-2469.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol.

Authors:  G F Bammert; J M Fostel
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray.

Authors:  M D De Backer; T Ilyina; X J Ma; S Vandoninck; W H Luyten; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Genetic analysis of azole resistance by transposon mutagenesis in Saccharomyces cerevisiae.

Authors:  D P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 4.  Lipopeptide inhibitors of fungal glucan synthase.

Authors:  M B Kurtz; C M Douglas
Journal:  J Med Vet Mycol       Date:  1997 Mar-Apr

5.  Sbe2p and sbe22p, two homologous Golgi proteins involved in yeast cell wall formation.

Authors:  B Santos; M Snyder
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

6.  Coordination between fission yeast glucan formation and growth requires a sphingolipase activity.

Authors:  A Feoktistova; P Magnelli; C Abeijon; P Perez; R L Lester; R C Dickson; K L Gould
Journal:  Genetics       Date:  2001-08       Impact factor: 4.562

7.  Distinct sets of SEC genes govern transport vesicle formation and fusion early in the secretory pathway.

Authors:  C A Kaiser; R Schekman
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

8.  Yeast 1,3-beta-glucan synthase activity is inhibited by phytosphingosine localized to the endoplasmic reticulum.

Authors:  M Abe; I Nishida; M Minemura; H Qadota; Y Seyama; T Watanabe; Y Ohya
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

Review 9.  Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.

Authors:  N H Georgopapadakou
Journal:  Expert Opin Investig Drugs       Date:  2001-02       Impact factor: 6.206

10.  Construction of a GAL1-regulated yeast cDNA expression library and its application to the identification of genes whose overexpression causes lethality in yeast.

Authors:  H Liu; J Krizek; A Bretscher
Journal:  Genetics       Date:  1992-11       Impact factor: 4.562

View more
  14 in total

1.  Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae.

Authors:  Sarit Markovich; Aya Yekutiel; Itamar Shalit; Yona Shadkchan; Nir Osherov
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 2.  Resistance to echinocandin-class antifungal drugs.

Authors:  David S Perlin
Journal:  Drug Resist Updat       Date:  2007-06-13       Impact factor: 18.500

Review 3.  Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

4.  Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways.

Authors:  Nathan P Wiederhold; Dimitrios P Kontoyiannis; Randall A Prince; Russell E Lewis
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Novel FKS mutations associated with echinocandin resistance in Candida species.

Authors:  Guillermo Garcia-Effron; Daniel Joseph Chua; Jon Rupert Tomada; Joseph DiPersio; David S Perlin; Mahmoud Ghannoum; Hector Bonilla
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

6.  Yapsins are a family of aspartyl proteases required for cell wall integrity in Saccharomyces cerevisiae.

Authors:  Damian J Krysan; Elizabeth L Ting; Claudia Abeijon; Lee Kroos; Robert S Fuller
Journal:  Eukaryot Cell       Date:  2005-08

7.  New methods to assess susceptibilities of Aspergillus isolates to caspofungin.

Authors:  Alexander Imhof; S Arunmozhi Balajee; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus.

Authors:  Wei Liu; Gregory S May; Michail S Lionakis; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

9.  Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin.

Authors:  Jason M Cota; Jodi L Grabinski; Robert L Talbert; David S Burgess; P David Rogers; Thomas D Edlind; Nathan P Wiederhold
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

10.  Caspofungin for the treatment of immunocompromised and severely ill children and neonates with invasive fungal infections.

Authors:  Nathan P Wiederhold; Lydia A Herrera
Journal:  Clin Med Insights Pediatr       Date:  2012-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.